Apotex to pay $24.1 million for fixing pravastatin prices
The Department of Justice has settled claims accusing Apotex of fixing the price of the generic drug pravastatin. The Florida-based company will pay a $24.1 million criminal fine....To view the full article, register now.
Already a subscriber? Click here to view full article